Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BREMEN Eye Drops vs Combigan in Open-Angle Glaucoma or Ocular Hypertension
NCT03235232Phase 3Completed
- Sponsor
- EMS
- Start
- Feb 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brimonidine, timolol in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by EMS. Started Feb 2021; status: completed.
02
Drugs
brimonidinetimolol
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT03235232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03235232.